Subject Index Vol. 217, 2008
Luigi Naldi(Centro Studi GISED), Zenus Saleh, Michael Meurer, Laurent Tisseau, Eugenia Caggese, Masaru Tanaka(Yamagata University), Emmanuel Laffitte(Hôpital Beau-Séjour), Takeshi Nakajima(Osaka International Cancer Institute), Paola Bertuccio, María Jones‐Caballero, Thomas Bieber(CK-CARE), Hitoshi Iyatomi, Gilles Safa, Alberto Giannetti(University of Modena and Reggio Emilia), Uta Schwanebeck, Antonio Addis(University of Toronto), Thomas Ruzicka(Ludwig-Maximilians-Universität München), Shigeki Inui(University of Rochester Medicine), Mirjana Urosevic, Reinhard Dummer(University Hospital of Zurich), Dagmar Wilsmann‐Theis(University Hospital Bonn), Benoît Bensaïd(Hospices Civils de Lyon), Xina Grählert, Carlo Tomino, Alexander Vasilevic Kuznetsov, Thierry Simonart(IS practice), Patrick A. Oberholzer(Sanofi (United States)), M. Loppin, Liliane Chatenoud(Mario Negri Institute for Pharmacological Research), Maria Rita Bongiorno(University of Palermo), Sergio Chimenti(University of Rome Tor Vergata), Masayuki Kimoto, Hans C. Steinert(University of Zurich), Jochen Schmitt(University Hospital Carl Gustav Carus), Mauro Picardo(Istituto Dermopatico dell'Immacolata), Natalija Novak(University Hospital Bonn), Gleison Vieira Duarte, Luca Borradori(University Dermatology), Knut Schäkel(Heidelberg University), Sonja Molin, J. Lamoril(Hôpital Bichat-Claude-Bernard), Peter Weisenseel, Michiie Sakamoto(Keio University), Mara Maccarone, Renato G. Panizzon, Rosanna Cuscito, Mario Aricò(University of Palermo), O. Lejeune, Satoshi Itami, Yuri Nogueira Chaves
Cited by 0
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Psoriasis Pathogenesis and Treatment
|International Journal of Molecular Sciences|2019|2k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
|Nature Medicine|2019|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k